Form 4 for BIO BIO-RAD LABORATORIES, INC.
Accepted 2024-05-01 00:00:00 ET · period of report 2023-05-03 · accession 0001062993-24-009134 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-05-01 | 2023-05-03 | BIO | SCHWARTZ STEVEN D | 10% | S - Sale | $463.86 | -320 | 1,498 | -18% | -$148.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Bio-Rad A Common Stock | 2023-05-03 | S | D | 320 | $463.86 | 1,498.03 | I By Spouse | — | — | (F1) Total reflects the number of shares beneficially owned by the insider as of the date of the report. (F2) The reporting person disclaims beneficial ownership of these shares. |